CAPTRUST Financial Advisors
AMPE

CAPTRUST Financial Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

CAPTRUST Financial Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-301
Closed -$5K – 2282
2022
Q3 		$5K Hold
301
– – ﹤0.01% 2043
2022
Q2 		$15K Hold
301
– – ﹤0.01% 3544
2022
Q1 		$42K Hold
301
– – ﹤0.01% 2921
2021
Q4 		$52K Sell
301
-74
-20% -$27.6K ﹤0.01% 2642
2021
Q3 		$187K Hold
375
– – ﹤0.01% 1610
2021
Q2 		$188K Buy
375
+2
+0.5% +$1.07K ﹤0.01% 1573
2021
Q1 		$189K Buy
373
+187
+101% +$96.4K ﹤0.01% 1520
2020
Q4 		$89K Buy
+186
New +$61K ﹤0.01% 1559

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

CAPTRUST Financial Advisors's AMPE Position: Q4 2022 in Review

CAPTRUST Financial Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 301 shares — an estimated $5K sold.

CAPTRUST Financial Advisors first reported a position in AMPE in Q4 2020 and held it in 8 quarters. The position peaked at $189K in Q1 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • CAPTRUST Financial Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 301 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $5K.
  • CAPTRUST Financial Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q4 2020 and held it in 8 quarters.
  • CAPTRUST Financial Advisors's Ampio Pharmaceuticals Inc. position peaked at $189K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.